Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Low Dose Continuous Treatment With Ciclesonide Over One Year on the Time to First Exacerbation in Children With Mild Asthma Versus Intermittent Treatment for Exacerbations

NCT00163293 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00163293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00163293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Low Dose Continuous Treatment With Ciclesonide Over One Year on the Time to First Exacerbation in Children With Mild Asthma Versus Intermittent Treatment for Exacerbations
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2005
Completion date
April 1, 2010
Enrollment
240 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

asthma